Scleroderma, Limited: Clinical Trials

1 trial for Scleroderma, Limited, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Scleroderma, Limited: new trials by email Literature Review of Scleroderma, Limited trials Research Report on Scleroderma, Limited

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
Mycophenolate Mofetil 500mg - Systemic Sclerosis, Limited Cutaneous Systemic Sclerosis
Phase 2UnknownUniversity College, London1202021-12-082023-07-27

Narrower conditions

Scleroderma, Systemic (1)

Broader conditions

Connective Tissue Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Mycophenolic Acid (1)

Sponsors

University College, London (1)

Countries

United Kingdom (1)

Top investigators

Christopher Denton (1)

NIH funding

2019 (1)